NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Chou R, Norris SL, Carson S, et al. Drug Class Review: Drugs for Neuropathic Pain: Final Report [Internet]. Portland (OR): Oregon Health & Science University; 2007 Oct.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Drug Class Review: Drugs for Neuropathic Pain

Drug Class Review: Drugs for Neuropathic Pain: Final Report [Internet].

Show details

References

1.
International Association for the Study of Pain. IASP Pain Terminology. 2007. [Accessed June 25th, 2007].
2.
Saarto Wiffen PJ. Antidepressants for neuropathic pain [Systematic Review] Cochrane Database Syst Rev. 2005;4:4. [PubMed: 16034979]
3.
Dworkin RH, Backonja M, Rowbotham M, et al. Advances in neuropathic pain. Diagnosis mechanisms, and treatment recommendations. Arch Neurol. 2003;60:1524–1534. [PubMed: 14623723]
4.
Hansson P, Laceremza M, Marchettini P. Aspects of clinical and experimental neuropathic pain: The clinical perspective. In: Hansson P, Fields HL, Hill RG, Marchettini P, editors. Neuropathic Pain: Pathophysiology and Treatment. Vol. 21. Seattle: IASP Press; 2001. pp. 1–18.
5.
Gilron I, Watson CPN, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. Cmaj. 2006 Aug 1;175(3):265–275. [PMC free article: PMC1513412] [PubMed: 16880448]
6.
Bennett GJ. Hosp Pract (Minneap) Vol. 10. 107. Neuropathic pain: new insights, new interventions. passim, 1998 Oct 15 1998;33(10):95–98. [PubMed: 9793544]
7.
Vinik AI, Mehrabyan A. Diabetic neuropathies. Med Clin North Am. 2004 Jul 2004;88(4):947–999. [PubMed: 15308387]
8.
Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes.[see comment] J Fam Pract. 2000 Nov;49(11 Suppl):S17–29. [PubMed: 11093555]
9.
Bowsher D. Pain, sensory change, and allodynia in postherpetic neuralgia. Herpes Zoster and Postherpetic Neuralgia. In: Watson CPN, GErshon AA, editors. Pain Research and Clinical Management. 2nd Revised and Enlarged Edition. Vol. 11. Elsevier Science; 2001. pp. 143–147.
10.
Crooks RJ, Jones DA, Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect Dis Suppl. 1991;80:62–68. [PubMed: 1803501]
11.
Jarvik JG, Deyo RA. Diagnostic evaluation of low back pain with emphasis on imaging. Ann Intern Med. 2002;137:586–597. [PubMed: 12353946]
12.
Wiffen Pj, McQuay, et al. Gabapentin for acute and chronic pain [Systematic Review] Cochrane Database Syst Rev. 2005;4:4. [PubMed: 16034978]
13.
Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002 Nov–Dec;18(6):355–365. [PubMed: 12441829]
14.
Bonezzi C, Demartini L. Treatment options in postherpetic neuralgia. Acta Neurol Scand Suppl. 1999;173:25–35. 48–52. [PubMed: 10819089]
15.
Soderpalm B. Anticonvulsants: aspects of their mechanisms of action. Eur J Pain. 2002;6(Suppl A):3–9. [PubMed: 11888234]
16.
Toma M, McAlister FA, Bialy L, Adams D, Vandermeer B, Armstrong PW. Transition from meeting abstract to full-length journal article for randomized controlled trials. Jama. 2006;295(11):1281–1287. [PubMed: 16537738]
17.
Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology. 2002;31(1):140–149. [PubMed: 11914310]
18.
Anonymous. Undertaking systematic reviews of research on effectiveness: CRD’s guidance for those carrying out or commissioning reviews CRD Report Number 4. 2. 2001.
19.
Harris RP, Helfand M, Woolf SH, et al. Current methods of the third U.S. Preventive Services Task Force. American Journal of Preventive Medicine. 2001;20(3S):21–35. [PubMed: 11306229]
20.
Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. Journal of Clinical Epidemiology. 1991;44(11):1271–1278. [PubMed: 1834807]
21.
Furlan AD, Clarke J, Esmail R, Sinclair S, Irvin E, Bombardier C. A critical review of reviews on the treatment of chronic low back pain. Spine. 2001;26(7):E155–E162. [PubMed: 11295917]
22.
Jadad AR, McQuay HJ. Meta-analyses to evaluate analgesic interventions: a systematic qualitative review of their methodology. Journal of Clinical Epidemiology. 1996;49:235–243. [PubMed: 8606325]
23.
Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for Meta-Analysis in Medical Research. 2000.
24.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun;21(11):1539–1558. [PubMed: 12111919]
25.
Team RDC. R: A Language and Environment for Statistical Computing. 2006.
26.
Egger M, Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315:629–634. [PMC free article: PMC2127453] [PubMed: 9310563]
27.
Sterne J, Egger M, Smith G. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. Bmj. 2001;323:101–105. [PMC free article: PMC1120714] [PubMed: 11451790]
28.
Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997 Jun;50(6):683–691. [PubMed: 9250266]
29.
Glenny AM, Altman DG, Song F, et al. Indirect comparisons of competing interventions. Health Technology Assessment. 2005;9(26):1–134. [PubMed: 16014203]
30.
Chou R, Fu R, Huffman LH, Korthuis PT. Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect analyses. Lancet. 2006;368:1503–1515. [PubMed: 17071284]
31.
Song F, Altman D, Glenny A-M, Deeks J. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. Bmj. 2003 March 1;326(7387):472. [PMC free article: PMC150178] [PubMed: 12609941]
32.
Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. Bmj. 2000;320:1574–1577. [PMC free article: PMC27401] [PubMed: 10845965]
33.
Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005 Dec 5;118(3):289–305. [PubMed: 16213659]
34.
Hempenstall K, Nurmikko TJ, Johnson RW, A’Hern RP, Rice ASC. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005 Jul;2(7):e164. [PMC free article: PMC1181872] [PubMed: 16013891]
35.
Khaliq W, Alam S, Puri N. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2007;(2):CD004846. [PubMed: 17443559]
36.
Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain [Systematic Review] Cochrane Database Syst Rev. 2005;4:4. [PubMed: 16034977]
37.
Wiffen P, Rees J. Lamotrigine for acute and chronic pain [Systematic Review] Cochrane Database Syst Rev. 2007;2:2. [PubMed: 17443611]
38.
Wong MS, Chung JW, Wong TKS. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. Bmj. 2007 [PMC free article: PMC1914460] [PubMed: 17562735]
39.
Chandra K, Shafiq N, Pandhi P, Gupta S, Malhotra S. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial. Int J Clin Pharmacol Ther. 2006 Aug;44(8):358–363. [PubMed: 16961166]
40.
Dallocchio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study. J Pain Symptom Manage. 2000 Oct;20(4):280–285. [PubMed: 11027910]
41.
Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain.[see comment] Arch Intern Med. 1999 Sep 13;159(16):1931–1937. [PubMed: 10493324]
42.
Sindrup SH, Bach FW, Madsen C, Gram LF, Jensen TS. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology. 2003 Apr 22;60(8):1284–1289. [PubMed: 12707430]
43.
Gartlehner G, Hansen RA, Nissman D, Lohr KN, Carey TS. A simple and valid tool distinguished efficacy from effectiveness studies. Journal of Clinical Epidemiology. 2006;59:1040–1048. [PubMed: 16980143]
44.
Galer BS, Rowbotham MC, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain. 1999 Apr;80(3):533–538. [PubMed: 10342414]
45.
Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003;106(1–2):151–158. [PubMed: 14581122]
46.
Raskin J, Smith TR, Wong K, et al. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain. J Palliat Med. 2006 Feb;9(1):29–40. [PubMed: 16430342]
47.
Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.[see comment] Jama. 1998 Dec 2;280(21):1831–1836. [PubMed: 9846777]
48.
Backonja MM. Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: a multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus. Epilepsia. 1999;40(Suppl 6):S57–59. S73–54. [PubMed: 10530684]
49.
Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg Anesth Pain Med. 2002 Sep–Oct;27(5):481–486. [PubMed: 12373695]
50.
Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain.[see comment] N Engl J Med. 2005 Mar 31;352(13):1324–1334. [PubMed: 15800228]
51.
Gorson KC, Schott C, Herman R, Ropper AH, Rand WM. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):251–252. [PMC free article: PMC1736215] [PubMed: 10071116]
52.
Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. 2004 Oct;251(10):1260–1266. [PubMed: 15503108]
53.
Levendoglu F, Ogun CO, Ozerbil O, Ogun TC, Ugurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine. 2004 Apr 16;29(7):743–751. [PubMed: 15087796]
54.
Rice AS, Maton S, Postherpetic Neuralgia Study G. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study.[see comment] Pain. 2001 Nov;94(2):215–224. [PubMed: 11690735]
55.
Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.[see comment] Jama. 1998 Dec 2;280(21):1837–1842. [PubMed: 9846778]
56.
Serpell MG. Neuropathic pain study group. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99(3):557–566. [PubMed: 12406532]
57.
Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. Journal of Clinical Neuromuscular Disease. 2001;3(2):53–62. [PubMed: 19078655]
58.
Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa JA. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med. 2002;25(2):100–105. [PubMed: 12137213]
59.
Yildirim K, Sisecioglu M, Karatay S, et al. The effectiveness of gabapentin in patients with chronic radiculopathy. The Pain Clinic. 2003;15(3):213–218.
60.
Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.[see comment] Neurology. 2003 Apr 22;60(8):1274–1283. [PubMed: 12707429]
61.
Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005 Jun;115(3):254–263. [PubMed: 15911152]
62.
Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 2004 Dec 14;63(11):2104–2110. [PubMed: 15596757]
63.
Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain. 2005 Apr;6(4):253–260. [PubMed: 15820913]
64.
Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004 Aug;110(3):628–638. [PubMed: 15288403]
65.
Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004 May;109(1–2):26–35. [PubMed: 15082123]
66.
Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy TK. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology. 2006 Nov 28;67(10):1792–1800. [PubMed: 17130411]
67.
van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin. 2006 Feb;22(2):375–384. [PubMed: 16466610]
68.
Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005 Jul;116(1–2):109–118. [PubMed: 15927394]
69.
Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005 Sep–Oct;6(5):346–356. [PubMed: 16266355]
70.
Wernicke JF, Pritchett YL, D’Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006 Oct 24;67(8):1411–1420. [PubMed: 17060567]
71.
Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.[erratum appears in Pain. 2005 Jan;113(1–2):248] Pain. 2004 Aug;110(3):697–706. [PubMed: 15288411]
72.
Tasmuth T, Hartel B, Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain. 2002;6(1):17–24. [PubMed: 11888224]
73.
Yucel A, Ozyalcin S, Koknel Talu G, et al. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. European journal of pain (London, England) 2005;9(4):407–416. [PubMed: 15979021]
74.
Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002 Sep–Oct;18(5):297–301. [PubMed: 12218500]
75.
Estanislao L, Carter K, McArthur J, Olney R, Simpson D, Lidoderm HIVNG. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1584–1586. [PubMed: 15577414]
76.
Rowbotham MC, Davies PS, Fields HL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 1995 Feb;37(2):246–253. [PubMed: 7847866]
77.
Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. 1996 Apr;65(1):39–44. [PubMed: 8826488]
78.
Cardenas DD, Warms CA, Turner JA, Marshall H, Brooke MM, Loeser JD. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain. 2002 Apr;96(3):365–373. [PubMed: 11973011]
79.
Hammack JE, Michalak JC, Loprinzi CL, et al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain. 2002;98(1–2):195–203. [PubMed: 12098632]
80.
Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain. 1996 Feb;64(2):293–302. [PubMed: 8740607]
81.
Kieburtz K, Simpson D, Yiannoutsos C, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology. 1998 Dec;51(6):1682–1688. [PubMed: 9855523]
82.
Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther. 1990 Mar;47(3):305–312. [PubMed: 2178851]
83.
Kvinesdal B, Molin J, Froland A, Gram LF. Imipramine treatment of painful diabetic neuropathy. Jama. 1984 Apr 6;251(13):1727–1730. [PubMed: 6366276]
84.
Leijon G, Boivie J. Central post-stroke pain–a controlled trial of amitriptyline and carbamazepine. Pain. 1989 Jan;36(1):27–36. [PubMed: 2465530]
85.
Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987 Apr;37(4):589–596. [PubMed: 2436092]
86.
Max MB, Kishore-Kumar R, Schafer SC, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 1991 Apr;45(1):3–9. 1–2. [PubMed: 1861872]
87.
Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology. 1988 Sep;38(9):1427–1432. [PubMed: 3412591]
88.
Panerai AE, Monza G, Movilia P, Bianchi M, Francucci BM, Tiengo M. A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain.[see comment] Acta Neurol Scand. 1990 Jul;82(1):34–38. [PubMed: 2239134]
89.
Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial.[see comment] Neurology. 2002 Oct 8;59(7):1015–1021. [PubMed: 12370455]
90.
Robinson LR, Czerniecki JM, Ehde DM, et al. Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study. Arch Phys Med Rehabil. 2004 Jan;85(1):1–6. [PubMed: 14970960]
91.
Shlay JC, Chaloner K, Max MB, et al. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.[see comment] Jama. 1998 Nov 11;280(18):1590–1595. [PubMed: 9820261]
92.
Sindrup SH, Ejlertsen B, Froland A, Sindrup EH, Brosen K, Gram LF. Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function. Eur J Clin Pharmacol. 1989;37(2):151–153. [PubMed: 2792168]
93.
Sindrup SH, Gram LF, Brosen K, Eshoj O, Mogensen EF. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 1990 Aug;42(2):135–144. [PubMed: 2147235]
94.
Sindrup SH, Gram LF, Skjold T, Grodum E, Brosen K, Beck-Nielsen H. Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. British Journal of Clinical Pharmacology. 1990 Nov;30(5):683–691. [PMC free article: PMC1368167] [PubMed: 2271367]
95.
Sindrup SH, Tuxen C, Gram LF, et al. Lack of effect of mianserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmacol. 1992;43(3):251–255. [PubMed: 1425887]
96.
Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindstrom T, Thorell LH. A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain. 1997 Dec;13(4):313–323. [PubMed: 9430812]
97.
Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology. 1982 Jun;32(6):671–673. [PubMed: 6283422]
98.
Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.[see comment] N Engl J Med. 1992 May 7;326(19):1250–1256. [PubMed: 1560801]
99.
Sindrup SH, Bjerre U, Dejgaard A, Brosen K, Aaes-Jorgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992 Nov;52(5):547–552. [PubMed: 1424428]
100.
Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966 Jun;29(3):265–267. [PMC free article: PMC496031] [PubMed: 5327969]
101.
Dalessio DJ. Medical treatment of tic douloureux. J Chronic Dis. 1966 Oct;19(10):1043–1048. [PubMed: 5966763]
102.
Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1966 Aug;15(2):129–136. [PubMed: 5329617]
103.
Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Use and side effects. Arch Neurol. 1968 Aug;19(2):129–136. [PubMed: 4877400]
104.
Rull JA, Quibrera R, Gonzalez-Millan H, Lozano Castaneda O. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial. Diabetologia. 1969 Aug;5(4):215–218. [PubMed: 4902717]
105.
Nicol CF. A four year double-blind study of tegretol in facial pain. Headache. 1969 Apr;9(1):54–57. [PubMed: 4896266]
106.
Drewes AM, Andreasen A, Poulsen LH. Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study. Paraplegia. 1994 Aug;32(8):565–569. [PubMed: 7970862]
107.
Kochar DK, Garg P, Bumb RA, et al. Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study. Qjm. 2005 Jan;98(1):29–34. [PubMed: 15625351]
108.
Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S. Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study.[see comment] Acta Neurol Scand. 2002 Nov;106(5):248–252. [PubMed: 12371916]
109.
Kochar DK, Rawat N, Agrawal RP, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM : monthly journal of the Association of Physicians. 2004 Jan;97(1):33–38. [PubMed: 14702509]
110.
Otto M, Bach FW, Jensen TS, Sindrup SH. Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial. Neurology. 2004 Jan 27;62(2):285–288. [PubMed: 14745070]
111.
Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology. 2001 Aug 14;57(3):505–509. [PubMed: 11502921]
112.
Finnerup NB, Sindrup SH, Bach FW, Johannesen IL, Jensen TS. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain. 2002 Apr;96(3):375–383. [PubMed: 11973012]
113.
McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial. Pain. 1999;83(1):105–107. [PubMed: 10506679]
114.
Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology. 2003 May 13;60(9):1508–1514. [PubMed: 12743240]
115.
Simpson DM, Olney R, McArthur JC, Khan A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy.[see comment] Neurology. 2000 Jun 13;54(11):2115–2119. [PubMed: 10851374]
116.
Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001 Jan 23;56(2):184–190. [PubMed: 11160953]
117.
Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial.[see comment] Pain. 1997 Nov;73(2):223–230. [PubMed: 9415509]
118.
Beydoun A, Shaibani A, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand. 2006 Jun;113(6):395–404. [PubMed: 16674606]
119.
Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain. 2005 Oct;9(5):543–554. [PubMed: 16139183]
120.
Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol. 2001 Mar–Apr;24(2):109–112. [PubMed: 11307048]
121.
Khoromi S, Patsalides A, Parada S, Salehi V, Meegan JM, Max MB. Topiramate in chronic lumbar radicular pain. J Pain. 2005 Dec;6(12):829–836. [PubMed: 16326371]
122.
Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 2004 Sep 14;63(5):865–873. [PubMed: 15365138]
123.
Thienel U, Neto W, Schwabe SK, Vijapurkar U, Topiramate Diabetic Neuropathic Pain Study G. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand. 2004 Oct;110(4):221–231. [PubMed: 15355485]
124.
Carlsson KC, Hoem NO, Moberg ER, Mathisen LC. Analgesic effect of dextromethorphan in neuropathic pain. Acta Anaesthesiol Scand. 2004;48(3):328–336. [PubMed: 14982566]
125.
McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design. Pain. 1994 Oct;59(1):127–133. [PubMed: 7854793]
126.
Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology. 1997 May;48(5):1212–1218. [PubMed: 9153445]
127.
Ferreira-Gonzalez I, Permanyer-Miralda G, Busse JW, et al. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. Journal of Clinical Epidemiology. 2007;60:651–657. [PubMed: 17573977]
128.
Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.[see comment] Pain. 2001 Nov;94(2):149–158. [PubMed: 11690728]
129.
Psaty PM, Lumley T, Furberg CD, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents. A network meta-analysis. Jama. 2003;289:2534–2544. [PubMed: 12759325]
130.
Chan A-W, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials. Jama. 2004;291:2457–2465. [PubMed: 15161896]
131.
Rothwell PM. External validity of randomised controlled trials: “To whom do the results of this trial apply?” The Lancet. 2005/1/1 2005;365(9453):82–93. [PubMed: 15639683]
Copyright © 2007, Oregon Health & Science University, Portland, Oregon.
Bookshelf ID: NBK10596
PubReader format: click here to try

Views

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...